Clinical Study of Cisplatin Combined with Vinorelbine、Gemzar and Docetaxel in Treatment of Advanced Non-Small Cell Lung Cancer

宋扬,冯英明,张贺龙,姬统理,闵婕,王宏
DOI: https://doi.org/10.3969/j.issn.1672-4992.2005.04.027
2005-01-01
Journal of Modern Oncology
Abstract:Objective To evaluate the effect and side reaction of three DDP-containing combined chemotherapy regimens in treatment of advanced non-small cell lung cancer(NSCLC).Methods Three DDP-containing combined chemotherapy regimens: NVB and DDP regimen(NP),GEM and DDP regimen(GP),TXT and DDP regimen(TP),were used to treat 78 patients of non-small cell lung cancer at stage Ⅲ~Ⅳ.31 patients were treated with NP,22 patients with GP and 25 patients with TP.Patients in three groups were well-matched in basic characteristics.Results The reponse rate was 29%(9/31) in group NP, 36%(8/22) in group GP and 40%(10/25) in group TP.The efficacy in three groups had no significant difference (P0.05).The main side reaction was hematologic toxicity.Conclusion DDP combined with NVB、GEM or TXT have definite efficacy in the patients with non-small cell lung cancer.There was no obvious difference among the three groups.All the three regimens can be applied to the first line chemotherapy.
What problem does this paper attempt to address?